Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer.

about

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q52717613

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer.

@en

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer.

@nl

type

Item

label

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer.

@en

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer.

@nl

prefLabel

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer.

@en

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer.

@nl

P1476

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer

@en

P2093

Mamoru Harada

http://www.w3.org/2001/XMLSchema#string

Nanae Harashima

http://www.w3.org/2001/XMLSchema#string

Takeshi Isobe

http://www.w3.org/2001/XMLSchema#string

Yukari Tsubata

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption

Cellular senescence in aging and age-related disease: from mechanisms to therapy

A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B12 in Japanese patients with solid tumours

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

Expression of thymidylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small-cell lung cancer: a systemic review and meta-analysis.

Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation.

H+-coupled nutrient, micronutrient and drug transporters in the mammalian small intestine

Pemetrexed induces S-phase arrest and apoptosis via a deregulated activation of Akt signaling pathway.

Decreased expression of the reduced folate carrier and folypolyglutamate synthetase is the basis for acquired resistance to the pemetrexed antifolate (LY231514) in an L1210 murine leukemia cell line.

The human proton-coupled folate transporter: Biology and therapeutic applications to cancer.

P304

16807-16821

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24704

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ryosuke Tanino

P577

2018-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29682186

http://www.w3.org/2001/XMLSchema#string

P932

5908287

http://www.w3.org/2001/XMLSchema#string